Literature DB >> 2462493

The insulin-like effect of vanadate on lipolysis in rat adipocytes is not accompanied by an insulin-like effect on tyrosine phosphorylation.

R A Mooney1, K L Bordwell, S Luhowskyj, J E Casnellie.   

Abstract

Tyrosine phosphorylation of the insulin receptor and other intracellular proteins in rat adipocytes was examined using an immunoblot technique with antiphosphotyrosine antibody. Insulin at 10(-7) M increased the tyrosine phosphorylation of the 95K subunit of the insulin receptor (15-fold) and proteins of 180K (7-fold) and 60K (23-fold). Increases in insulin-dependent phosphorylation of the three proteins were detectable at 10(-10) M insulin and attained steady state within 30 sec of insulin (10(-7) M) addition. Small effects of insulin (less than 30% increases) were observed on proteins of 120K and 53K. In contrast to insulin, the effects of vanadate on tyrosine phosphorylation were small and nonspecific. Vanadate increased tyrosine phosphorylation of the 95K insulin receptor beta-subunit and the 120K and 60K proteins similarly, with increases of 1.5- to 3-fold at 1 mM and 2-fold or less at 200 and 50 microM. Vanadate-dependent tyrosine phosphorylation of the 180K protein increased to a maximum of only 30% at 200 microM. Tyrosine phosphorylation of the 53K protein was somewhat larger, approaching 4-fold at 1 mM vanadate. The concentration of insulin and vanadate that inhibited isoproterenol-dependent lipolysis were not comparable to those that increased tyrosine phosphorylation. Vanadate at 1 mM was more potent as an antilipolytic agent than 10(-9) M insulin (93% vs. 81%), yet increased tyrosine phosphorylation of the 95K insulin receptor beta-subunit only as effectively as 10(-10) M insulin (which inhibited lipolysis only 42%). The dissimilar responses were even more pronounced when antilipolysis was compared to tyrosine phosphorylation of the 180K and 60K proteins. For example, insulin at 10(-9) M increased tyrosine phosphorylation of the 180K protein 2.9-fold, while 1 mM vanadate had a negligible effect (10% increase). Thus, vanadate exerts an insulin-like effect on lipolysis, yet its effects on tyrosine phosphorylation differ from those of insulin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2462493     DOI: 10.1210/endo-124-1-422

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

1.  Oral administration of vanadate to streptozotocin-diabetic rats restores the glucose-induced activation of liver glycogen synthase.

Authors:  M Bollen; M Miralpeix; F Ventura; B Toth; R Bartrons; W Stalmans
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

Review 2.  Effects of vanadyl derivatives on animal models of diabetes.

Authors:  G Cros; J J Mongold; J J Serrano; S Ramanadham; J H McNeill
Journal:  Mol Cell Biochem       Date:  1992-02-12       Impact factor: 3.396

Review 3.  Alternative therapies for diabetes and its cardiac complications: role of vanadium.

Authors:  Tod A Clark; Justin F Deniset; Clayton E Heyliger; Grant N Pierce
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

4.  In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals.

Authors:  R L Khandelwal; S Pugazhenthi
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

5.  Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy.

Authors:  M B Anand-Srivastava; J H McNeill; X P Yang
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

6.  In vivo effects of peroxovanadium compounds in BB rats.

Authors:  J F Yale; C Vigeant; C Nardolillo; Q Chu; J Z Yu; A Shaver; B I Posner
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

7.  Decrease in protein tyrosine phosphatase activities in vanadate-treated obese Zucker (fa/fa) rat liver.

Authors:  S Pugazhenthi; F Tanha; B Dahl; R L Khandelwal
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

8.  Vanadium salts stimulate mitogen-activated protein (MAP) kinases and ribosomal S6 kinases.

Authors:  S K Pandey; J L Chiasson; A K Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 9.  Vanadium and diabetes.

Authors:  P Poucheret; S Verma; M D Grynpas; J H McNeill
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

10.  Increasing cAMP attenuates activation of mitogen-activated protein kinase.

Authors:  B R Sevetson; X Kong; J C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.